trending Market Intelligence /marketintelligence/en/news-insights/trending/adel-5ee03mcz8jrtdsyqg2 content esgSubNav
In This List

PharmAust CEO resigns

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


PharmAust CEO resigns

PharmAust Ltd. said Richard Hopkins resigned as CEO to pursue a senior corporate position at another company, effective May 25.

The company's executive chairman, Roger Aston, will become PharmAust's acting CEO following Hopkins' departure.

Australia's PharmAust operates as a drug discovery and development company primarily in Australia and Switzerland.